Kymera Therapeutics (KYMR) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Kymera Therapeutics (KYMR) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Kymera Therapeutics

· KYMR

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

9.189 B

+1.16%

General

Market Cap: $9.19B
Enterprise Value: $9.15B
Shares Outstanding: 82,260,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 101.98%
Operating Margin: -333.54%
Net Profit Margin: -285.41%
FCF Margin: -226.65%
ROA: -18.21%
ROE: -21.50%
ROIC: -22.14%
Current Ratio: 9.83
Debt-to-Equity: 0.05
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 87.59
P/FCF: —
P/B: 6.09
EV/EBITDA: -31.27

Growth

Rev 1Y: -16.72%
Rev 1Y Fwd Est: 167.93%
Rev 3Y (CAGR): -5.75%
Rev 5Y (CAGR): 2.87%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $104.99M
Gross Margin: 101.98%
Operating Expenses: $457.25M
Operating Income: -$350.18M
Net Profit: -$299.65M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $124.48M
Working Capital: $662.28M
Total Assets: $1.65B
Net Debt: -$42.26M
Total Liabilities: $139.85M
Total Equity: $1.51B

Cash Flow Statement (TTM)

Cash Flow from Operations: -$236.76M
Cash Flow from Investing: -$752.49M
Cash Flow from Financing: $777.92M
Free Cash Flow: -$237.96M
Capital Expenditures: $1.19M